Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00459602 · ClinicalTrials.gov registry record
Incisional Hernia Outcomes Study Using Parietex Composite Mesh
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 22
- Enrollment target
NCT00459602: Clinical Trial study, sponsored by Columbia University.
NCT00459602 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00459602 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to describe the outcomes of laparoscopic incisional hernia repair surgery and to record the outcomes of patients after surgery.
Primary Outcome
pain assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2004-08 |
| Est. Completion | 2008-09 |
Why NCT00459602 stopped before completion
NCT00459602 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00459602 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00459602 about?
NCT00459602 is a clinical study titled "Incisional Hernia Outcomes Study Using Parietex Composite Mesh". The purpose of this study is to describe the outcomes of laparoscopic incisional hernia repair surgery and to record the outcomes of patients after surgery.
What is the current status of trial NCT00459602?
This trial is currently terminated. The enrollment target is 22 participants. The study started on 2004-08. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00459602?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia